Thrombolysis is one of the main strategies to treat ischemic stroke, and recombinant tissue plasminogen activator (rtPA) as a thrombolysis agent is now usually employed to alleviate the ischemic stroke through dissolving intravascular thrombus [2, 3]. This evidence concerns the gene PLAT and ischemic stroke.